Additionally, we compared the expression of RCAN1-4 between GBM cell lines with a classical subtype (SF10281) and those with a mesenchymal subtype (SF10360), both of which were derived from primary untreated GBM patients [38]. Here, RCAN1 is linked to glioblastoma.